1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        South and Central America Metastatic Cancer Drugs Market – By Cancer Type

1.3.2        South and Central America Metastatic Cancer Drugs Market – By Route of Administration

1.3.3        South and Central America Metastatic Cancer Drugs Market – By Drug Class

1.3.4        South and Central America Metastatic Cancer Drugs Market – By Product

1.3.5        South and Central America Metastatic Cancer Drugs Market – By End User

1.3.6        South and Central America Metastatic Cancer Drugs Market – By Country

2.           South and Central America Metastatic Cancer Drugs Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           South and Central America Metastatic Cancer Drugs Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America– PEST Analysis

4.3         Expert Opinion

5.           South and Central America Metastatic Cancer Drugs Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Prevalence of Metastatic Cancer

5.1.2        Government Initiatives to Support Developments in Cancer Treatment

5.2         Market Restraints

5.2.1        High Cost of Oncology Drugs

5.3         Market Opportunities

5.3.1        Investments in Artificial Intelligence for Oncology Drug Development

5.4         Future Trends

5.4.1        Increase in Launch of Metastatic Cancer Drugs

5.5         Impact analysis

6.           South and Central America Metastatic Cancer Drugs Market – Country Analysis

6.1         South and Central America Metastatic Cancer Drugs Market Revenue Forecast and Analysis

6.1.1        South and Central America Metastatic Cancer Drugs Market, By Country - Forecast and Analysis to 2028 (USD Million)

7.           South and Central America Metastatic Cancer Drug Market Analysis – By Cancer Type

7.1         Overview

7.2         South and Central America Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)

7.2.1        South and Central America: South and Central America Metastatic Cancer Drug Market, by Cancer Type, 2019–2028 (USD Million)

7.3         Breast Cancer

7.3.1        Overview

7.3.2        Breast Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Lung Cancer

7.4.1        Overview

7.4.2        Lung Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Liver Cancer

7.5.1        Overview

7.5.2        Liver Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Hematological Cancer

7.6.1        Overview

7.6.2        Hematological Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.7         Brain Cancer

7.7.1        Overview

7.7.2        Brain Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.8         Prostate Cancer

7.8.1        Overview

7.8.2        Prostate Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.9         Pancreatic Cancer

7.9.1        Overview

7.9.2        Pancreatic Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

7.10      Others

7.10.1     Overview

7.10.2     Others: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.           South and Central America Metastatic Cancer Drug Market – By Route of Administration

8.1         Overview

8.2         South and Central America Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)

8.2.1        South and Central America: South and Central America Metastatic Cancer Drug Market, by Route of Administration, 2019–2028 (USD Million)

8.3         Intravenous

8.3.1        Overview

8.3.2        Intravenous: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Intramuscular

8.4.1        Overview

8.4.2        Intramuscular: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Oral

8.5.1        Overview

8.5.2        Oral: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.           South and Central America Metastatic Cancer Drug Market – By Drug Class

9.1         Overview

9.2         South and Central America Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)

9.2.1        South and Central America: South and Central America Metastatic Cancer Drug Market, by Drug Class, 2019–2028 (USD Million)

9.3         HER2 Inhibitors

9.3.1        Overview

9.3.2        HER2 Inhibitors: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Immune Checkpoints Inhibitors

9.4.1        Overview

9.4.2        Immune Checkpoints Inhibitors: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.5         PARP Inhibitors

9.5.1        Overview

9.5.2        PARP Inhibitors: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Kinase Inhibitors

9.6.1        Overview

9.6.2        Kinase Inhibitors: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Others

9.7.1        Overview

9.7.2        Others: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

10.        South and Central America Metastatic Cancer Drug Market – By Product

10.1      Overview

10.2      South and Central America Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)

10.2.1     South and Central America: South and Central America Metastatic Cancer Drug Market, by Product, 2019–2028 (USD Million)

10.3      Branded

10.3.1     Overview

10.3.2     Branded: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Generics and Biosimilars

10.4.1     Overview

10.4.2     Generics and Biosimilars: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11.        South and Central America Metastatic Cancer Drug Market – By End User

11.1      Overview

11.2      South and Central America Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)

11.2.1     South and Central America: South and Central America Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

11.3      Hospital

11.3.1     Overview

11.3.2     Hospitals: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11.4      Specialty Clinic

11.4.1     Overview

11.4.2     Specialty Clinics: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

11.5      Others

11.5.1     Overview

11.5.2     Others: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

12.        South and Central America Metastatic Cancer Drugs Market – Regional Analysis

12.1      South and Central America: South and Central America Metastatic Cancer Drugs Market

12.1.1     Overview

12.1.2     South and Central America: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028  (USD Million)

12.1.3     South and Central America: South and Central America Metastatic Cancer Drug Market, by Country, 2021 & 2028 (%)

12.1.3.1       Brazil: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.1.1       Brazil: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.1.2       Brazil: South and Central America Metastatic Cancer Drug Market, by Cancer Type, 2019–2028 (USD Million)

12.1.3.1.3       Brazil: South and Central America Metastatic Cancer Drug Market, by Route of Administration, 2019–2028 (USD Million)

12.1.3.1.4       Brazil: South and Central America Metastatic Cancer Drug Market, by Drug Class, 2019–2028 (USD Million)

12.1.3.1.5       Brazil: South and Central America Metastatic Cancer Drug Market, by Product, 2019–2028 (USD Million)

12.1.3.1.6       Brazil: South and Central America Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

12.1.3.2       Argentina: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.2.1       Argentina: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.2.2       Argentina: South and Central America Metastatic Cancer Drug Market, by Cancer Type, 2019–2028 (USD Million)

12.1.3.2.3       Argentina: South and Central America Metastatic Cancer Drug Market, by Route of Administration, 2019–2028 (USD Million)

12.1.3.2.4       Argentina: South and Central America Metastatic Cancer Drug Market, by Drug Class, 2019–2028 (USD Million)

12.1.3.2.5       Argentina: South and Central America Metastatic Cancer Drug Market, by Product, 2019–2028 (USD Million)

12.1.3.2.6       Argentina: South and Central America Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

12.1.3.3       Rest of South and Central America: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.3.1       Rest of South and Central America: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

12.1.3.3.2       Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by Cancer Type, 2019–2028 (USD Million)

12.1.3.3.3       Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by Route of Administration, 2019–2028 (USD Million)

12.1.3.3.4       Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by Drug Class, 2019–2028 (USD Million)

12.1.3.3.5       Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by Product, 2019–2028 (USD Million)

12.1.3.3.6       Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by End User, 2019–2028 (USD Million)

13.        South and Central America Metastatic Cancer Drug Market –Industry Landscape

13.1      Overview

13.2      Growth Strategies in the South and Central America Metastatic Cancer Drug Market, 2021-2028

13.3      Inorganic Developments

13.3.1     Overview

13.4      Organic Growth Strategies

13.4.1     Overview

14.        Company Profiles

14.1      AbbVie Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Amgen Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Bristol-Myers Squibb Company

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      F. HOFFMANN-LA ROCHE LTD.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Novartis AG

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Astrazeneca

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7      MERCK KGaA

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8      Pfizer Inc. (Arena Pharmaceutical GmbH)

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9      Johnson and Johnson Services, Inc.

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

15.        Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             South and Central America: South and Central America Metastatic Cancer Drug Market, by Country – Revenue and Forecast to 2028 (USD Million)

Table 2.             South and Central America: South and Central America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             South and Central America: South and Central America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4.             South and Central America: South and Central America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 5.             South and Central America: South and Central America Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 6.             South and Central America: South and Central America Metastatic Cancer Drug Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 7.             Brazil: South and Central America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 8.             Brazil: South and Central America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 9.             Brazil: South and Central America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 10.          Brazil: South and Central America Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 11.          Brazil: South and Central America Metastatic Cancer Drug Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 12.          Argentina: South and Central America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          Argentina: South and Central America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Argentina: South and Central America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 15.          Argentina: South and Central America Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 16.          Argentina: South and Central America Metastatic Cancer Drug Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.          Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)

Table 18.          Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 19.          Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by Drug Class – Revenue and Forecast to 2028 (USD Million)

Table 20.          Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by Product– Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of South and Central America: South and Central America Metastatic Cancer Drug Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 22.          Recent Inorganic Growth Strategies in the South and Central America Metastatic Cancer Drug Market

Table 23.          Recent Organic Growth Strategies in the South and Central America Metastatic Cancer Drug Market

Table 24.          Glossary of Terms, South and Central America Metastatic Cancer Drugs Market

LIST OF FIGURES

Figure 1.           South and Central America Metastatic Cancer Drugs Market Segmentation

Figure 2.           South and Central America Metastatic Cancer Drugs Market Overview

Figure 3.           The PARP Inhibitors Segment Held The Largest Share of Drug Class Segment in South and Central America Metastatic Cancer Drugs Market

Figure 4.           Rest of SCAM Is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           South & Central America PEST Analysis

Figure 6.           Expert Opinion

Figure 7.           South and Central America Metastatic Cancer Drugs Market Impact Analysis of Driver and Restraints

Figure 8.           South and Central America Metastatic Cancer Drugs Market – Revenue Forecast and Analysis – 2021- 2028

Figure 9.           South and Central America Metastatic Cancer Drug Market Revenue Share, by Cancer Type (2021 and 2028)

Figure 10.        Breast Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.        Lung Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Liver Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Hematological Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Brain Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Prostate Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Pancreatic Cancer: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Others: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        South and Central America Metastatic Cancer Drug Market, by Route of Administration, 2021 and 2028 (%)

Figure 19.        Intravenous: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Intramuscular: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Oral: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Others: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        South and Central America Metastatic Cancer Drug Market, by Drug Class, 2021 and 2028 (%)

Figure 24.        HER2 Inhibitors: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Immune Checkpoints Inhibitors: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        PARP Inhibitors: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Kinase Inhibitors: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Others: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        South and Central America Metastatic Cancer Drug Market, by Product, 2021 and 2028 (%)

Figure 30.        Branded: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Generics and Biosimilars: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        South and Central America Metastatic Cancer Drug Market, by End User, 2021 and 2028 (%)

Figure 33.        Hospitals: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        Specialty Clinics: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Others: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        South and Central America: South and Central America Metastatic Cancer Drugs Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 37.        South and Central America South and Central America Metastatic Cancer Drug Market Revenue and Forecast to 2028 (USD Million)

Figure 38.        South and Central America: South and Central America Metastatic Cancer Drug Market, by Country, 2021 & 2028 (%)

Figure 39.        Brazil: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Argentina: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Rest of South and Central America: South and Central America Metastatic Cancer Drug Market – Revenue and Forecast to 2028  (USD Million)

Figure 42.        Growth Strategies in the South and Central America Metastatic Cancer Drug Market, 2021-2028